JDRF Hawaii Community Partnership

08/12/2019

For our T1D families: These JDRF volunteers are available to answer your questions about T1D and get you through this difficult time. Don’t worry, you are not alone.

The Online Diabetes Support Team (ODST) is made up of compassionate volunteers who know firsthand the ever-changing demands of living with type 1 diabetes (T1D). Contact us with your questions, and we will do our best to respond with an email within 48 hours (we are not medical or legal professional...

08/12/2019

It’s that time again -- ! 🚌

JDRF is here to help you make the first day and every day after safe, easy and fun! Find all of our school resources here: http://ow.ly/Bsco30pjWv7

08/06/2019

"Yesterday, the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to teplizumab, an anti-CD3 monoclonal antibody, for the prevention or delay of type 1 ( ) in individuals at-risk of developing the disease. CD3 is a blood marker that helps to activate the immune cells—called T cells—which are thought to be responsible for the disease."

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to teplizumab, an anti-CD3 monoclonal antibody, for the prevention or delay...

07/12/2019

Have you met Emi, your JDRF Children's Congress representative for Hawaii? Emi traveled to Washington, DC, this week to advocate for families. Thank you for all your hard work, Emi!!

04/09/2019

"Cigna's newly announced Express Scripts program to reduce out-of-pocket costs for insulin is a step in the right direction. It is unconscionable for anyone to struggle to access insulin, and through our campaign, JDRF has long advocated for health plans to implement policies that make insulin more affordable, including practical solutions to improve coverage and lower out-of-pocket costs, so all who need it can access this life-saving drug. We are encouraged by Cigna taking this action and urge them to implement this program without delay. We also encourage eligible employers to opt into this program."

Aaron Kowalski, PhD, JDRF Chief Mission Officer

Cigna and Express Scripts on Wednesday announced a plan to cap out-of-pocket insulin costs at $25 for a 30-day supply for eligible plan members with diabetes, according to a press release from the companies. The Patient Assurance Program will be available to members in participating non-government f...

04/04/2019

This week, JDRF's Chief Mission Officer Aaron Kowalski testified before the Subcommittee on Oversight and Investigations on the Committee on Energy and Commerce. The hearing was entitled "Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs"

"Right now, our system is failing people with diabetes. We need systemic change, change that Congress can help make happen.

A recent study from Yale found up to 25 percent of people with diabetes are actually taking less insulin than what they need, just to save on costs.

No one should suffer or die because they cannot access insulin."

Please click below to read more about JDRF's stance on the skyrocketing cost of insulin and its life or death impact.

Our system is failing people with diabetes. We need systemic change, change that Congress can help make happen.

11/03/2018

Has National Diabetes Awareness Month (NDAM) inspired you to do more to advance research? If you are between the ages of 4-17, apply to represent JDRF Hawaii next summer at JDRF 2019 Children's Congress! Deadline is November 30! http://cc.jdrf.org